APOBEC1 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "APOBEC1" in English language version.

Last modified: 05:54:03, 25 June 2026 (UTC)

Ref.Un. Ref.Website

Global rank English rank

3430nih.gov

5^th place

2119doi.org

2^nd place

62ensembl.org

630^th place

326^th place

51web.archive.org

1^st place

51oyageninc.com

low place

11adsabs.harvard.edu

14^th place

9^th place

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

ui.adsabs.harvard.edu

Lau PP, Chang BH, Chan L (April 2001). "Two-hybrid cloning identifies an RNA-binding protein, GRY-RBP, as a component of apobec-1 editosome". Biochemical and Biophysical Research Communications. 282 (4): 977–983. Bibcode:2001BBRC..282..977L. doi:10.1006/bbrc.2001.4679. PMID 11352648.

doi.org (Global: 2^nd place; English: 2^nd place)

Rosenberg BR, Hamilton CE, Mwangi MM, Dewell S, Papavasiliou FN (2011). "Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs". Nature Structural & Molecular Biology. 18 (2): 230–236. doi:10.1038/nsmb.1975. PMC 3075553. PMID 21258325.
Teng BB, Ochsner S, Zhang Q, Soman KV, Lau PP, Chan L (1999). "Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization". Journal of Lipid Research. 40 (4): 623–635. doi:10.1016/S0022-2275(20)32141-6. PMID 10191286.
Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, Scott J, et al. (2002). "An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22". Genomics. 79 (3): 285–296. doi:10.1006/geno.2002.6718. PMID 11863358.
Gee P, Ando Y, Kitayama H, Yamamoto SP, Kanemura Y, Ebina H, et al. (2011). "APOBEC1-mediated editing and attenuation of herpes simplex virus 1 DNA indicate that neurons have an antiviral role during herpes simplex encephalitis". Journal of Virology. 85 (19): 9726–9736. doi:10.1128/JVI.05288-11. PMC 3196441. PMID 21775448.
Yang Y, Ballatori N, Smith HC (2002). "Apolipoprotein B mRNA editing and the reduction in synthesis and secretion of the atherogenic risk factor, apolipoprotein B100 can be effectively targeted through TAT-mediated protein transduction". Molecular Pharmacology. 61 (2): 269–276. doi:10.1124/mol.61.2.269. PMID 11809850.
Blanc V, Davidson NO (2011). "Mouse and Other Rodent Models of C to U RNA Editing". RNA and DNA Editing. Methods in Molecular Biology. Vol. 718. pp. 121–135. doi:10.1007/978-1-61779-018-8_7. ISBN 978-1-61779-017-1. PMC 3608419. PMID 21370045.
von Wronski MA, Hirano KI, Cagen LM, Wilcox HG, Raghow R, Thorngate FE, et al. (1998). "Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes". Metabolism. 47 (7): 869–873. doi:10.1016/s0026-0495(98)90128-7. PMID 9667237.
Yang Y, Sowden MP, Yang Y, Smith HC (2001). "Intracellular trafficking determinants in APOBEC-1, the catalytic subunit for cytidine to uridine editing of apolipoprotein B mRNA". Experimental Cell Research. 267 (2): 153–164. doi:10.1006/excr.2001.5255. PMID 11426934.
MacGinnitie AJ, Anant S, Davidson NO (1995). "Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity". The Journal of Biological Chemistry. 270 (24): 14768–14775. doi:10.1074/jbc.270.24.14768. PMID 7782343.
Lehmann DM, Galloway CA, Sowden MP, Smith HC (2006). "Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor". Nucleic Acids Research. 34 (11): 3299–3308. doi:10.1093/nar/gkl417. PMC 1500872. PMID 16820530.
Nakamuta M, Chang BH, Zsigmond E, Kobayashi K, Lei H, Ishida BY, et al. (1996). "Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1". The Journal of Biological Chemistry. 271 (42): 25981–25988. doi:10.1074/jbc.271.42.25981. PMID 8824235.
Chen Z, Eggerman TL, Bocharov AV, Baranova IN, Vishnyakova TG, Csako G, et al. (2010). "Hypermutation induced by APOBEC-1 overexpression can be eliminated". RNA. 16 (5). New York, N.Y.: 1040–1052. doi:10.1261/rna.1863010. PMC 2856876. PMID 20348446.
Gonzalez MC, Suspène R, Henry M, Guétard D, Wain-Hobson S, Vartanian JP (2009). "Human APOBEC1 cytidine deaminase edits HBV DNA". Retrovirology. 6 96. doi:10.1186/1742-4690-6-96. PMC 2770521. PMID 19843348.
Niavarani A, Shahrabi Farahani A, Sharafkhah M, Rassoulzadegan M (March 2018). "Pancancer analysis identifies prognostic high-APOBEC1 expression level implicated in cancer in-frame insertions and deletions". Carcinogenesis. 39 (3): 327–335. doi:10.1093/carcin/bgy005. PMID 29346513.
Mukhopadhyay D, Anant S, Lee RM, Kennedy S, Viskochil D, Davidson NO (2002). "C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme". American Journal of Human Genetics. 70 (1): 38–50. doi:10.1086/337952. PMC 384902. PMID 11727199.
Blanc V, Navaratnam N, Henderson JO, Anant S, Kennedy S, Jarmuz A, et al. (March 2001). "Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing". The Journal of Biological Chemistry. 276 (13): 10272–10283. doi:10.1074/jbc.M006435200. PMID 11134005.
Mehta A, Kinter MT, Sherman NE, Driscoll DM (March 2000). "Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA". Molecular and Cellular Biology. 20 (5): 1846–1854. doi:10.1128/MCB.20.5.1846-1854.2000. PMC 85365. PMID 10669759.
Lau PP, Chan L (December 2003). "Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing". The Journal of Biological Chemistry. 278 (52): 52988–52996. doi:10.1074/jbc.M310153200. PMID 14559896.
Lau PP, Chang BH, Chan L (April 2001). "Two-hybrid cloning identifies an RNA-binding protein, GRY-RBP, as a component of apobec-1 editosome". Biochemical and Biophysical Research Communications. 282 (4): 977–983. Bibcode:2001BBRC..282..977L. doi:10.1006/bbrc.2001.4679. PMID 11352648.

ensembl.org (Global: 630^th place; English: 326^th place)

may2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000111701 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000040613 – Ensembl, May 2017

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Rosenberg BR, Hamilton CE, Mwangi MM, Dewell S, Papavasiliou FN (2011). "Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs". Nature Structural & Molecular Biology. 18 (2): 230–236. doi:10.1038/nsmb.1975. PMC 3075553. PMID 21258325.
Teng BB, Ochsner S, Zhang Q, Soman KV, Lau PP, Chan L (1999). "Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization". Journal of Lipid Research. 40 (4): 623–635. doi:10.1016/S0022-2275(20)32141-6. PMID 10191286.
Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, Scott J, et al. (2002). "An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22". Genomics. 79 (3): 285–296. doi:10.1006/geno.2002.6718. PMID 11863358.
Gee P, Ando Y, Kitayama H, Yamamoto SP, Kanemura Y, Ebina H, et al. (2011). "APOBEC1-mediated editing and attenuation of herpes simplex virus 1 DNA indicate that neurons have an antiviral role during herpes simplex encephalitis". Journal of Virology. 85 (19): 9726–9736. doi:10.1128/JVI.05288-11. PMC 3196441. PMID 21775448.
Yang Y, Ballatori N, Smith HC (2002). "Apolipoprotein B mRNA editing and the reduction in synthesis and secretion of the atherogenic risk factor, apolipoprotein B100 can be effectively targeted through TAT-mediated protein transduction". Molecular Pharmacology. 61 (2): 269–276. doi:10.1124/mol.61.2.269. PMID 11809850.
Blanc V, Davidson NO (2011). "Mouse and Other Rodent Models of C to U RNA Editing". RNA and DNA Editing. Methods in Molecular Biology. Vol. 718. pp. 121–135. doi:10.1007/978-1-61779-018-8_7. ISBN 978-1-61779-017-1. PMC 3608419. PMID 21370045.
von Wronski MA, Hirano KI, Cagen LM, Wilcox HG, Raghow R, Thorngate FE, et al. (1998). "Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes". Metabolism. 47 (7): 869–873. doi:10.1016/s0026-0495(98)90128-7. PMID 9667237.
Yang Y, Sowden MP, Yang Y, Smith HC (2001). "Intracellular trafficking determinants in APOBEC-1, the catalytic subunit for cytidine to uridine editing of apolipoprotein B mRNA". Experimental Cell Research. 267 (2): 153–164. doi:10.1006/excr.2001.5255. PMID 11426934.
MacGinnitie AJ, Anant S, Davidson NO (1995). "Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity". The Journal of Biological Chemistry. 270 (24): 14768–14775. doi:10.1074/jbc.270.24.14768. PMID 7782343.
Lehmann DM, Galloway CA, Sowden MP, Smith HC (2006). "Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor". Nucleic Acids Research. 34 (11): 3299–3308. doi:10.1093/nar/gkl417. PMC 1500872. PMID 16820530.
Nakamuta M, Chang BH, Zsigmond E, Kobayashi K, Lei H, Ishida BY, et al. (1996). "Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1". The Journal of Biological Chemistry. 271 (42): 25981–25988. doi:10.1074/jbc.271.42.25981. PMID 8824235.
Chen Z, Eggerman TL, Bocharov AV, Baranova IN, Vishnyakova TG, Csako G, et al. (2010). "Hypermutation induced by APOBEC-1 overexpression can be eliminated". RNA. 16 (5). New York, N.Y.: 1040–1052. doi:10.1261/rna.1863010. PMC 2856876. PMID 20348446.
Gonzalez MC, Suspène R, Henry M, Guétard D, Wain-Hobson S, Vartanian JP (2009). "Human APOBEC1 cytidine deaminase edits HBV DNA". Retrovirology. 6 96. doi:10.1186/1742-4690-6-96. PMC 2770521. PMID 19843348.
Niavarani A, Shahrabi Farahani A, Sharafkhah M, Rassoulzadegan M (March 2018). "Pancancer analysis identifies prognostic high-APOBEC1 expression level implicated in cancer in-frame insertions and deletions". Carcinogenesis. 39 (3): 327–335. doi:10.1093/carcin/bgy005. PMID 29346513.
Mukhopadhyay D, Anant S, Lee RM, Kennedy S, Viskochil D, Davidson NO (2002). "C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme". American Journal of Human Genetics. 70 (1): 38–50. doi:10.1086/337952. PMC 384902. PMID 11727199.
Blanc V, Navaratnam N, Henderson JO, Anant S, Kennedy S, Jarmuz A, et al. (March 2001). "Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing". The Journal of Biological Chemistry. 276 (13): 10272–10283. doi:10.1074/jbc.M006435200. PMID 11134005.
Mehta A, Kinter MT, Sherman NE, Driscoll DM (March 2000). "Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA". Molecular and Cellular Biology. 20 (5): 1846–1854. doi:10.1128/MCB.20.5.1846-1854.2000. PMC 85365. PMID 10669759.
Lau PP, Chan L (December 2003). "Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing". The Journal of Biological Chemistry. 278 (52): 52988–52996. doi:10.1074/jbc.M310153200. PMID 14559896.
Lau PP, Chang BH, Chan L (April 2001). "Two-hybrid cloning identifies an RNA-binding protein, GRY-RBP, as a component of apobec-1 editosome". Biochemical and Biophysical Research Communications. 282 (4): 977–983. Bibcode:2001BBRC..282..977L. doi:10.1006/bbrc.2001.4679. PMID 11352648.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: APOBEC1 apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1".
Rosenberg BR, Hamilton CE, Mwangi MM, Dewell S, Papavasiliou FN (2011). "Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs". Nature Structural & Molecular Biology. 18 (2): 230–236. doi:10.1038/nsmb.1975. PMC 3075553. PMID 21258325.
Gee P, Ando Y, Kitayama H, Yamamoto SP, Kanemura Y, Ebina H, et al. (2011). "APOBEC1-mediated editing and attenuation of herpes simplex virus 1 DNA indicate that neurons have an antiviral role during herpes simplex encephalitis". Journal of Virology. 85 (19): 9726–9736. doi:10.1128/JVI.05288-11. PMC 3196441. PMID 21775448.
Blanc V, Davidson NO (2011). "Mouse and Other Rodent Models of C to U RNA Editing". RNA and DNA Editing. Methods in Molecular Biology. Vol. 718. pp. 121–135. doi:10.1007/978-1-61779-018-8_7. ISBN 978-1-61779-017-1. PMC 3608419. PMID 21370045.
Lehmann DM, Galloway CA, Sowden MP, Smith HC (2006). "Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor". Nucleic Acids Research. 34 (11): 3299–3308. doi:10.1093/nar/gkl417. PMC 1500872. PMID 16820530.
Chen Z, Eggerman TL, Bocharov AV, Baranova IN, Vishnyakova TG, Csako G, et al. (2010). "Hypermutation induced by APOBEC-1 overexpression can be eliminated". RNA. 16 (5). New York, N.Y.: 1040–1052. doi:10.1261/rna.1863010. PMC 2856876. PMID 20348446.
Gonzalez MC, Suspène R, Henry M, Guétard D, Wain-Hobson S, Vartanian JP (2009). "Human APOBEC1 cytidine deaminase edits HBV DNA". Retrovirology. 6 96. doi:10.1186/1742-4690-6-96. PMC 2770521. PMID 19843348.
Mukhopadhyay D, Anant S, Lee RM, Kennedy S, Viskochil D, Davidson NO (2002). "C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme". American Journal of Human Genetics. 70 (1): 38–50. doi:10.1086/337952. PMC 384902. PMID 11727199.
Mehta A, Kinter MT, Sherman NE, Driscoll DM (March 2000). "Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA". Molecular and Cellular Biology. 20 (5): 1846–1854. doi:10.1128/MCB.20.5.1846-1854.2000. PMC 85365. PMID 10669759.

oyageninc.com (Global: low place; English: low place)

Smith H (12 September 2008). "The APOBEC1 Paradigm for Mammalian Cytidine Deaminases That Edit DNA and RNA" (PDF). In Henri G (ed.). DNA and RNA Modification Enzymes: Comparative Structure, Mechanism, Functions, Cellular Interactions and Evolution. Landes Bioscience. Archived from the original (PDF) on 4 March 2014. Retrieved 24 February 2014.

web.archive.org (Global: 1^st place; English: 1^st place)

Smith H (12 September 2008). "The APOBEC1 Paradigm for Mammalian Cytidine Deaminases That Edit DNA and RNA" (PDF). In Henri G (ed.). DNA and RNA Modification Enzymes: Comparative Structure, Mechanism, Functions, Cellular Interactions and Evolution. Landes Bioscience. Archived from the original (PDF) on 4 March 2014. Retrieved 24 February 2014.

APOBEC1 (English Wikipedia)

adsabs.harvard.edu (Global: 14th place; English: 9th place)